RIBOCICLIB-TABLETTE

European patent · EP3283058 · In force

Register entry

Publication number
EP3283058
Application number
EP16718020
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 14, 2016
Published
Feb 21, 2018
Granted
Nov 16, 2022
Protection ends at the latest
Apr 13, 2036
Next annual fee due
Apr 30, 2027
IPC classes
A61K 9/20 (2006.01)
Priority
US 201562148240 P 16.04.2015
PCT application
PCT/IB2016/052136 14.04.2016
PCT publication
WO2016/166703 20.10.2016
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 1, 2026

    Change

    Published in Swissreg on 01.05.2026

  2. May 1, 2025

    Change

    Published in Swissreg on 01.05.2025

  3. May 1, 2024

    Change

    Published in Swissreg on 01.05.2024

  4. Aug 23, 2023

    Change

    Published in Swissreg on 23.08.2023

  5. Aug 23, 2023

    Change

    Published in Swissreg on 23.08.2023

  6. Aug 23, 2023

    Change

    Published in Swissreg on 23.08.2023

  7. May 1, 2023

    Change

    Published in Swissreg on 01.05.2023

  8. Nov 16, 2022

    Granted

    Published in Swissreg on 16.11.2022

Parties

Holder

Novartis AG

Lichtstrasse 35, 4056 Basel

Inventor

GRANDEURY, Arnaud

4002 Basel

GURURAJAN, Bindhumadhavan

4002 Basel

COSTA, Rui

4002 Basel

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.